Neuromuscular Block and Anesthetic Depth Monitoring

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02575443

Enrollment

Registered

2015-10-14

Start date

2015-09-30

Completion date

2017-09-30

Last updated

2018-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholecystectomy, Laparoscopic

Brief summary

The purpose of this study is to evaluated whether the depth of neuromuscular block may affect the unicon value of anesthetic depth monitoring system (ADMS).

Interventions

DRUGRocuronium (MB group)

Count of train-of-four: 1-2 Titration of rocuronium dose

DRUGRocuronium (DB group)

Post-tetanic count: 1-2 Titration of rocuronium dose

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Gall bladder disease * American Society of Anesthesiologist physical status 1 or 2

Exclusion criteria

* Pregnancy * Body mass index \< 16 * Body mass index \>30 * Neuromuscular disease * Previous intraabdominal surgery

Design outcomes

Primary

Measure	Time frame
Total infused dose of propofol	At 1 min after the anesthesia is finished

Secondary

Measure	Time frame
Electromyographic index presented on the anesthetic depth monitoring system	Through study completion, an average of 2 hours

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026